Minnesota-based biopharmaceutical company ANI Pharmaceuticals, Inc. is gaining traction in the US and Canadian markets with its focus on branded and generic prescription pharmaceuticals. The company is committed to producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations, including extended release and combination products. ANI Pharmaceuticals also manufactures oral solid dose products, semi-solids, liquids, and topicals, as well as performs contract development and manufacturing of pharmaceutical products. The company's retail distribution strategy includes partnerships with pharmacy chains, wholesalers, distributors, mail order pharmacies, and group purchasing organizations. Founded in 2001, ANI Pharmaceuticals continues to expand its offerings and industry reach.
ANI Pharmaceuticals's ticker is ANIP
The company's shares trade on the NASDAQ stock exchange
They are based in Baudette, Minnesota
There are 201-500 employees working at ANI Pharmaceuticals
It is anipharmaceuticals.com
ANI Pharmaceuticals is in the Healthcare sector
ANI Pharmaceuticals is in the Biotechnology industry
The following five companies are ANI Pharmaceuticals's industry peers: